Skip to main content
China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
0.564
-0.024 (-4.13%)
At close: Apr 28, 2026, 4:00 PM EDT
0.564
0.00 (0.00%)
After-hours: Apr 28, 2026, 8:00 PM EDT

China Pharma Holdings Revenue

In the year 2025, China Pharma Holdings had annual revenue of $4.14M, down -8.49%. China Pharma Holdings had revenue of $1.23M in the quarter ending December 31, 2025, with 8.11% growth.

Revenue (ttm)
$4.14M
Revenue Growth
-8.49%
P/S Ratio
5.51
Revenue / Employee
$19,276
Employees
215
Market Cap
22.85M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20254.14M-384.66K-8.49%
Dec 31, 20244.53M-2.48M-35.41%
Dec 31, 20237.01M-1.09M-13.48%
Dec 31, 20228.10M-1.54M-15.95%
Dec 31, 20219.64M-1.22M-11.27%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
InterCure 72.16M
Rockwell Medical 69.26M
Aytu BioPharma 62.64M
Biofrontera 41.71M
Zhengye Biotechnology Holding 21.46M
TherapeuticsMD 3.02M
BioXcel Therapeutics 642.00K
Talphera 28.00K
Revenue Rankings

CPHI News

More News